Alunbrig Tablet, Film Coated
Product Images NDC 63020-113
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Alunbrig (NDC 63020-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (30 mg Tablet Bottle Label)
Principal Display Panel (90 mg Tablet Bottle Label)
Principal Display Panel (180 mg Tablet Bottle Label)
This is a description of "ALUNBRIG" tablets containing brigatinib. Each tablet of ALUNBRIG contains 90 mg of brigatinib and the recommended storage temperature is between 20°C to 25°C. It is a prescription medicine and the details should be obtained from the prescribing information. Additionally, it warns to keep the medicine away from children. The NDC number for ALUNBRIG is 6302009030 and 6302003030.*
Principal Display Panel (Kit Carton)
Alunbrig 06
This is a medication initiation pack for Alunbrig (brigatinib) tablets with different doses of 90mg and 180mg. The usual dosage for the first seven days is one tablet of 90mg orally once per day, then if tolerated, it can be increased to one tablet of 180mg orally once a day. The pack contains 7 tablets of 90mg, 23 tablets of 180mg, and detailed prescribing information. The tablets should be kept away from children and stored between 15 to 30°C.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.